Bloomberg News reported earlier that Goldman's unit had beaten other potential buyers for Synthon and could value the drugmaker at about 2 billion euros ($2.1 billion).

BC Partners has entered into exclusive talks for the acquisition of a minority stake in EuroLeague, giving it an advantage over other competitors such as General Atlantic and Riyadh's SURJ Sports Investment in the race to acquire a stake in the top basketball competition on the Old Continent.